Androgenetic Alopecia Treatment Market 2025–2029: Unveiling Growth Developments with the Latest Updates
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
How Much Will The Androgenetic Alopecia Treatment Market Be Worth By 2029?
In recent times, the market size for the treatment of androgenetic alopecia has observed robust growth. It is projected to escalate from $2.29 billion in 2024 to $2.44 billion in 2025, registering a compound annual growth rate (CAGR) of 6.9%. Such growth in the historical timeframe could be credited to a focus on enhancing patient results and life quality, a rise in the elderly population, and an upsurge in health care spending.
In the coming years, a robust expansion is anticipated in the market for androgenetic alopecia treatment. The expectation is that the market will augment to $3.19 billion by 2029, experiencing a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth prediction for the given period include the increasing incidents of hair loss, the pervasiveness of severe health conditions such as cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis, and the high demand for effective measures to tackle hair loss issues. The market trends for the forecast period are expected to be driven by partnerships, product authorizations, investments, as well as research and developments.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15721&type=smp
What Underlying Factors Are Supporting The Androgenetic Alopecia Treatment Market Growth?
A surge in incidents of hair loss is anticipated to stimulate the expansion of the androgenetic alopecia treatment market. Alopecia, or hair loss, denotes the partial or total loss of hair from the scalp or other parts of the body. Factors contributing to hair loss include hormonal shifts, genetic factors, nutritional deficiencies, and elevated stress. Various methods are employed in androgenetic alopecia treatments, such as hormonal control, follicle stimulation, and surgical restoration, to curb hair loss and stimulate hair regrowth. For example, a March 2022 article from the Hair Society, a professional organization based in the U.S., stated that hair loss influenced around 21 million women and 35 million men worldwide. In 2024, the UK’s National Health Service reported that roughly 8 million women and 6.5 million men in the UK suffered from hair loss. Furthermore, over 650,000 hair transplants are completed yearly. Hence, the escalating number of hair loss instances fuels the growth of the androgenetic alopecia treatment market.
What Are The Key Segment Trends Observed In The Androgenetic Alopecia Treatment Market?
The androgenetic alopecia treatment market covered in this report is segmented –
1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users
Subsegments:
1) By Pharmaceutical: Oral Medications ( Finasteride), Topical Medications (Minoxidil), Hormonal Therapy
2) By Device: Laser Therapy Devices, Hair Transplant Devices, Scalp Micropigmentation Devices
Which Disruptive Trends Are Driving Change Across The Androgenetic Alopecia Treatment Market?
Key players in the androgenetic alopecia treatment market are pioneering advanced drug alternatives that tackle hair loss by stimulating hair follicle rejuvenation, deterring hair loss-inducing hormones, and leveraging innovative delivery mechanisms such as topical applications and oral drugs. For example, Pfizer Inc., a healthcare company headquartered in the USA, gained FDA approval in June 2023 for LITFULO (ritlecitinib), a daily oral treatment for those aged 12 and above suffering from severe alopecia areata. LITFULO, a kinase inhibitor, inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in the hepatocellular carcinoma (TEC) family of kinases. The FDA’s approval hinged on the ALLEGRO Phase 2b/3 study, wherein 23% of patients administered with LITFULO 50mg realized 80% or more scalp hair coverage after a six-month period, contrasting with 1.6% on a placebo. This solution offers a novel alternative for those grappling with significant hair loss, filling an existing gap in the treatment of alopecia areata.
Who Are The Major Stakeholders Operating In The Androgenetic Alopecia Treatment Market?
Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy’s Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Androgenetic Alopecia Treatment Market?
North America was the largest region in the androgenetic alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15721&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
